INVESTIGATION OF EFFICACY OF ANTI-TUMOR PREVENTIVE VACCINATIONS WITH THE USE OF BACTERIAL PHAGELYSATES IN EXPERIMENTAL STUDIES

INVESTIGATION OF EFFICACY OF ANTI-TUMOR PREVENTIVE VACCINATIONS WITH THE USE OF BACTERIAL PHAGELYSATES IN EXPERIMENTAL STUDIES

Authors

  • Ketevan Gambashidze
  • Paata Khorava
  • N. Bejitashvili
  • N. PKHALADZE
  • T.N. AZALADZE
  • Besarion Lasareishvili
  • A.T. AZALADZE
  • Eka Jaiani
  • M.I. TEDIASHVILI

Abstract

We were aimed to investigate anti-tumor preventive potential of E. coli pagelysate vaccinations in experiment. Investigations were carried out on 2-3 months 48 male mice. Regimen of preventive vaccinations were: single - 0,25 ml E.coli phagelysate intraperitoneal injection, 3 days before Ehrlich carcinoma inoculation (1x106 tumor cells), and 3 times vaccinations - 0,25 ml E.coli phagelysate injections with 5 day intervals, 3, 6, and 9 days before inoculation of carcinoma. Treatment efficacy was evaluated according to the indices of cancer growth (development of cancer tissue, cancer growth inhibition percent, lifespan and survival percent). Results were analyzed statistically with the use of SPSS 16.0 for Windows.  Experiments have shown that single and 3 times preventive E.coli phagelysate vaccinations are well tolerated in mice and do not stimulate malignant growth. 

Vaccinations inhibited tumor development and delayed the malignant growth. Cancer growth inhibition percent in vaccinated animals were 55% on the average. Maximal lifespan in control group  mice consisted 59 days.  By the 125th day of cancer growth, at single preventive vaccination, the 17% of mice were alive, while in 3 times vaccinated mice, the survival percent was 25%. Anti-tumor potential of E.coli pagelysate supposedly could be explained by immunoregulatory properties of preparation.

Downloads

Download data is not yet available.

References

Gambashidze, K. G., Khorava, P. A., Kalandarishvili, K. G., Lasareishvili, B. G., Dzhaiani, E. G., Azaladze, A. T., & Tediashvili, M. I. (2012). Application of bacterial thermo-and phagelysates for suppression of malignant tumor growth in experimental studies: 1. Anticancer efficacy of thermo-and phagelysates of E. coli. Georgian Medical News, (202), 42-47.

Stassen M. et al. - The streptococcal exotoxin streptolysin O activates mast cells to produce tumor necrosis factor alpha by p38 mitogen-activated protein kinase- and protein-kinase C dependent pathways// Inf. Immunity, 2003, 71(11), 6171-6177.

Wang J. et al. - Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, inteleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole bllod model// Inf. Immunity, 2000, 68(7), 3965-3969.

Downloads

Published

2023-08-26

How to Cite

Gambashidze, K., Khorava, P., Bejitashvili, N., PKHALADZE, N., AZALADZE , T., Lasareishvili, B., … TEDIASHVILI , M. (2023). INVESTIGATION OF EFFICACY OF ANTI-TUMOR PREVENTIVE VACCINATIONS WITH THE USE OF BACTERIAL PHAGELYSATES IN EXPERIMENTAL STUDIES. Experimental and Clinical Medicine Georgia, (2), 63–66. Retrieved from https://journals.4science.ge/index.php/jecm/article/view/1982

Issue

Section

Articles

Most read articles by the same author(s)

Loading...